Mebias Discovery Raises $3.5 Million to Expand Pipeline Using a Novel, Cell Signaling-Pathway Selective GPCR Drug Discovery Platform

Developing Programs to Focus on GI and Inflammation Therapies with Reduced, or No, Side Effects 

See more here


Pillo Health And BLACK+DECKER Partner To Deliver Smart Home Care Companion

See more here


Varian and Oncora Partner to Accelerate Precision Medicine in Radiation Oncology

See more here


VenatoRx Pharmaceuticals Names Joseph C. Larsen, Ph.D. Vice President, Strategic Portfolio Development

See more here


VenatoRx Pharmaceuticals Initiates Enrollment in Phase 3 Trial of Cefepime/VNRX-5133 in Patients with Complicated Urinary Tract Infections
– Demonstrated potent activity against carbapenem-resistant Enterobacteriaceae and carbapenem-resistant Pseudomonas aeruginosa 
– VNRX-5133 may provide a therapeutic option for these emerging pathogens, which are classified as urgent public health threats by the Centers for Disease Control and Prevention

See more here


Bainbridge Health Partners with Tabula Rasa HealthCare’s subsidiary DoseMe To Expand Medication Management Capabilities to Health Systems(s)

See more here


VenatoRx Pharmaceuticals Expands Development Team as It Advances Its Antibacterial and Antiviral Portfolio
Key Hires in Quality Assurance, Medical Sciences and Regulatory Affairs 

See more here


Group K Diagnostics and Health Network Laboratories Announce the Commencement of a Clinical Trial

See more here


Renovacor Closes $11 Million Series A Financing to Advance First Gene Therapy for a Rare Cardiovascular Disease
– Funding supports preclinical development through IND submission for its BAG3 gene therapy, the first gene replacement product for genetic forms of dilated cardiomyopathy
– Company announces leadership team and board of directors with leading scientists, physicians and experienced venture investors in cardiovascular and gene therapy fields

See more here